SARSYS (SARS) Q3 2024 earnings summary

Executive summary

• Net sales for Q3 2024 increased to 12.2 MSEK from 11.5 MSEK year-over-year, but operating profit declined to -2 MSEK from 0.7 MSEK.

• For the first nine months, net sales fell 11% to 28.3 MSEK, and operating profit worsened to -9.9 MSEK from -0.7 MSEK year-over-year.

• Gross margin dropped to 51% from 57%, and equity per share turned negative at -0.01 SEK.

• The company faces critical financial challenges, with negative equity and urgent capital needs.

Financial highlights

• Q3 2024 net sales: 12.2 MSEK (Q3 2023: 11.5 MSEK); 9M 2024: 28.3 MSEK (9M 2023: 31.8 MSEK).

• Q3 2024 operating profit: -2 MSEK (Q3 2023: 0.7 MSEK); 9M 2024: -9.9 MSEK (9M 2023: -0.7 MSEK).

• EPS for Q3 2024: -0.17 SEK (Q3 2023: 0.03 SEK); 9M 2024: -0.77 SEK (9M 2023: -0.14 SEK).

• Cash flow from operations for 9M 2024: -5.6 MSEK (9M 2023: 5.0 MSEK); cash at period end: 1 MSEK.

• Equity ratio at -3% (9M 2023: 17%); net debt increased to 15.8 MSEK.

Outlook and guidance

• Focus on cost optimization, resource efficiency, and new revenue streams to restore profitability.

• Board is considering a new share issue to address urgent capital needs of approximately 20 MSEK.